Shine-On BioMedical Co.,Ltd. (TPEX:6926)
Taiwan · Delayed Price · Currency is TWD 64.50
+0.70 (1.10%)
May 8, 2026, 11:57 AM CST
Shine-On BioMedical Revenue
In the year 2025, Shine-On BioMedical had annual revenue of 30.00M TWD. Shine-On BioMedical had revenue of 30.00M in the half year ending December 31, 2025, with 214.99% growth.
Revenue
30.00M
Revenue Growth
n/a
P/S Ratio
107.07
Revenue / Employee
n/a
Employees
22
Market Cap
3.21B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 30.00M | - | - |
| Dec 31, 2024 | - | - | - |
| Dec 31, 2023 | 9.52M | - | - |
| Dec 31, 2022 | - | - | - |
| Dec 31, 2021 | - | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Apex Biotechnology | 1.94B |
| SYN-TECH Chem. & Pharm. | 1.30B |
| Chunghwa Chemical Synthesis & Biotech | 804.88M |
| Genovate Biotechnology | 492.41M |
| HeXun Biosciences | 293.23M |
| BioGend Therapeutics | 229.81M |
| Intech Biopharm | 107.53M |
| Energenesis Biomedical CO.,LTD. | 7.67M |